CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 205 enrolled
Drug / intervention
Placebo +1 moredrug
Likely dose
Placebo 400 unitsfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01375660
NCT01375660N/ACompleted
CompareCT.gov

Vitamin D Deficiency and Treatment in Male Veterans at Risk for Diabetes

US Department of Veterans Affairs·interventional·Posted Jun 17, 2011·Updated Mar 6, 2015

In Brief

A clinical study evaluating Placebo and 50K vitamin D2 for Impaired Fasting Glucose and 2 related conditions. Completed, enrolled 205 participants across 1 site.

Detailed Summary

This study will supplement African American male (AAM) veterans at risk for diabetes and newly diagnosed T2DM with vitamin D (low or higher dose) and evaluate whether vitamin D helps to improve early markers of diabetes. The study will be done at Veteran Administration Medical Center in Chicago.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsImpaired Fasting Glucose, Impaired Glucose Tolerance, Vitamin D Insufficiency
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedJun 17, 2011
Enrollment StartMay 1, 2011
Primary CompletionOct 1, 2013
Study CompletionNov 1, 2014
TodayJul 2, 2026
Enrollment to primary: 2.4 yearsPosted 15.0 years ago

Interventions

Placebodrug

Supplement of vitamin D 400 units provided to all subjects, in addition Arm 1 will get placebo and Arm 2 will get D2 50K

50K vitamin D2drug

Supplement of vitamin D 400 units provided to all subjects, in addition Arm 1 will get placebo and Arm 2 will get D2 50K